A new publication from a team of authors that includes multiple members of the RID Program, including Dr. Chelsea Elwood, Dr. Julie van Schalkwyk, and Melissa Watt has been accepted by Allergy, Asthma, & Clinical Immunology and will be published in a future issue of the journal! This publication entitled “Reliability and validation of an electronic penicillin allergy risk-assessment tool in a pregnant population” describes findings from research conducted out of the Penicillin Allergy Challenge Clinic at BC Women’s Hospital. The research was conducted to determine if an electronic assessment tool/algorithm that was developed by the study team was reliable and accurate at predicting non-allergy/potential for delabelling of patients who were referred to the Penicillin Allergy Challenge Clinic in pregnancy, by comparing the results of this assessment tool to two other electronic assessment tools as well as the actual clinical results/findings. Key findings described in the publication include the study team-developed algorithm performing very well at predicting non-allergy/delabelling of patients with it having very strong predictive values, and these predictive values even surpassing the values of the other two electronic assessment tools. For more information and to read more about these and other findings, access the publication here!